Opinicus Capital, Inc. Novo Nordisk A S Transaction History
Opinicus Capital, Inc.
- $113 Billion
- Q1 2024
A detailed history of Opinicus Capital, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Opinicus Capital, Inc. holds 4,818 shares of NVO stock, worth $676,591. This represents 0.55% of its overall portfolio holdings.
Number of Shares
4,818Holding current value
$676,591% of portfolio
0.55%Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,864Shares Held
310MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$2.96 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.93 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.83 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.69 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.66 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $317B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...